Vitamin Shoppe Inc. (NYSE:VSI) CAO Dan Lamadrid sold 1,734 shares of the stock in a transaction dated Tuesday, November 8th. The stock was sold at an average price of $23.20, for a total transaction of $40,228.80. The sale was disclosed in a legal filing with the SEC, which is available at this link.

Vitamin Shoppe Inc. (NYSE:VSI) opened at 25.30 on Monday. The firm has a market cap of $592.80 million, a P/E ratio of 14.92 and a beta of 0.66. The firm has a 50-day moving average of $26.24 and a 200-day moving average of $28.34. Vitamin Shoppe Inc. has a 12-month low of $21.90 and a 12-month high of $34.41.

Vitamin Shoppe (NYSE:VSI) last announced its quarterly earnings results on Wednesday, November 2nd. The company reported $0.50 earnings per share (EPS) for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.50. The business earned $314.90 million during the quarter, compared to analyst estimates of $317.18 million. Vitamin Shoppe had a return on equity of 11.52% and a net margin of 3.34%. The firm’s revenue was up .3% on a year-over-year basis. During the same period in the previous year, the company earned $0.52 EPS. On average, analysts expect that Vitamin Shoppe Inc. will post $2.14 EPS for the current year.

Several brokerages have recently weighed in on VSI. Zacks Investment Research upgraded shares of Vitamin Shoppe from a “strong sell” rating to a “hold” rating in a report on Thursday, October 6th. Morgan Stanley lowered shares of Vitamin Shoppe from an “overweight” rating to an “equal weight” rating and cut their price objective for the stock from $32.00 to $26.00 in a report on Thursday, November 3rd. Barclays PLC reiterated an “equal weight” rating and set a $29.00 price objective on shares of Vitamin Shoppe in a report on Wednesday, November 2nd. Jefferies Group reiterated a “hold” rating and set a $28.00 price objective on shares of Vitamin Shoppe in a report on Monday, September 26th. Finally, JPMorgan Chase & Co. lowered shares of Vitamin Shoppe from an “overweight” rating to a “neutral” rating and cut their price objective for the stock from $33.00 to $28.00 in a report on Thursday, October 27th. Two analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has issued a buy rating to the stock. Vitamin Shoppe currently has an average rating of “Hold” and an average target price of $31.46.

Several large investors have recently made changes to their positions in the stock. Weiss Asset Management LP purchased a new stake in shares of Vitamin Shoppe during the third quarter valued at about $237,000. Citadel Advisors LLC raised its stake in shares of Vitamin Shoppe by 20,677.9% in the third quarter. Citadel Advisors LLC now owns 228,557 shares of the company’s stock valued at $6,137,000 after buying an additional 227,457 shares in the last quarter. Morgan Stanley raised its stake in shares of Vitamin Shoppe by 112.8% in the third quarter. Morgan Stanley now owns 155,539 shares of the company’s stock valued at $4,176,000 after buying an additional 82,453 shares in the last quarter. GMT Capital Corp purchased a new stake in shares of Vitamin Shoppe during the third quarter valued at about $7,586,000. Finally, Northern Trust Corp raised its stake in shares of Vitamin Shoppe by 0.9% in the third quarter. Northern Trust Corp now owns 313,988 shares of the company’s stock valued at $8,431,000 after buying an additional 2,786 shares in the last quarter.

Vitamin Shoppe Company Profile

Vitamin Shoppe, Inc (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins, minerals, herbs, specialty supplements, sports nutrition, and other health and wellness products. The Company operates through three segments: retail, which includes Vitamin Shoppe, Super Supplements and Vitapath retail store formats; direct, which sells its products directly to consumers through the Internet, primarily at www.vitaminshoppe.com, and manufacturing, which provides custom manufacturing and private labeling of vitamin, mineral and supplement (VMS) products.

5 Day Chart for NYSE:VSI

Receive News & Stock Ratings for Vitamin Shoppe Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe Inc. and related stocks with our FREE daily email newsletter.